UMIN-CTR Clinical Trial
| Unique ID issued by UMIN | UMIN000027577 |
|---|---|
| Receipt number | R000031616 |
| Scientific Title | Prospective study of the relationship between patient with high CRP levels and antibiotic therapy |
| Date of disclosure of the study information | 2017/06/01 |
| Last modified on | 2017/05/31 18:53:14 |
* This page includes information on clinical trials registered in UMIN clinical trial registed system.
* We don't aim to advertise certain products or treatments
Basic information
Public title
Prospective study of the relationship between patient with high CRP levels and antibiotic therapy
Acronym
Prospective study of the relationship between patient with high CRP levels and antibiotic therapy
Scientific Title
Prospective study of the relationship between patient with high CRP levels and antibiotic therapy
Scientific Title:Acronym
Prospective study of the relationship between patient with high CRP levels and antibiotic therapy
Region
| Japan |
Condition
Condition
Patients with CRP values greater than 15 mg / L
Classification by specialty
| Medicine in general | Infectious disease | Laboratory medicine |
| Adult |
Classification by malignancy
Others
Genomic information
NO
Objectives
Narrative objectives1
Antimicrobial drug use rate
Basic objectives2
Others
Basic objectives -Others
Factor analysis that did not use antimicrobial drug
Trial characteristics_1
Exploratory
Trial characteristics_2
Developmental phase
Assessment
Primary outcomes
Implementation rate of antibiotic therapy
Key secondary outcomes
Base
Study type
Observational
Study design
Basic design
Randomization
Randomization unit
Blinding
Control
Stratification
Dynamic allocation
Institution consideration
Blocking
Concealment
Intervention
No. of arms
Purpose of intervention
Type of intervention
Interventions/Control_1
Interventions/Control_2
Interventions/Control_3
Interventions/Control_4
Interventions/Control_5
Interventions/Control_6
Interventions/Control_7
Interventions/Control_8
Interventions/Control_9
Interventions/Control_10
Eligibility
Age-lower limit
| 18 | years-old | <= |
Age-upper limit
| 110 | years-old | >= |
Gender
Male and Female
Key inclusion criteria
CRP > 15 mg/L
in-patient
out-patient
Key exclusion criteria
Pediatric patient
Target sample size
50
Research contact person
Name of lead principal investigator
| 1st name | |
| Middle name | |
| Last name | Fukuda Tetsuya |
Organization
Nishi Saitama Chuo Hospital
Division name
Department of Pharmacy
Zip code
Address
2-1671 wakasa, Tokorozawa Saitama 359-1151, Japan.
TEL
04-2948-1111
fukudatetsuya-ph@umin.ac.jp
Public contact
Name of contact person
| 1st name | |
| Middle name | |
| Last name | Fukuda Tetsuya |
Organization
Nishi Saitama Chuo Hospital
Division name
Department of Pharmacy
Zip code
Address
2-1671 wakasa, Tokorozawa Saitama 359-1151, Japan.
TEL
04-2948-1111
Homepage URL
fukudatetsuya-ph@umin.ac.jp
Sponsor or person
Institute
Nishi Saitama Chuo Hospital
Institute
Department
Personal name
Funding Source
Organization
Nishi Saitama Chuo Hospital
Organization
Division
Category of Funding Organization
Self funding
Nationality of Funding Organization
Other related organizations
Co-sponsor
Name of secondary funder(s)
IRB Contact (For public release)
Organization
Address
Tel
Secondary IDs
Secondary IDs
NO
Study ID_1
Org. issuing International ID_1
Study ID_2
Org. issuing International ID_2
IND to MHLW
Institutions
Institutions
Other administrative information
Date of disclosure of the study information
| 2017 | Year | 06 | Month | 01 | Day |
Related information
URL releasing protocol
Publication of results
Unpublished
Result
URL related to results and publications
Number of participants that the trial has enrolled
Results
Results date posted
Results Delayed
Results Delay Reason
Date of the first journal publication of results
Baseline Characteristics
Participant flow
Adverse events
Outcome measures
Plan to share IPD
IPD sharing Plan description
Progress
Recruitment status
Preinitiation
Date of protocol fixation
| 2017 | Year | 05 | Month | 22 | Day |
Date of IRB
Anticipated trial start date
| 2017 | Year | 06 | Month | 01 | Day |
Last follow-up date
Date of closure to data entry
Date trial data considered complete
Date analysis concluded
Other
Other related information
Implementation rate of antibiotic therapy
28-day mortality
qSOFA
time to antibiotics
duration of antibiotic therapy
Management information
Registered date
| 2017 | Year | 05 | Month | 31 | Day |
Last modified on
| 2017 | Year | 05 | Month | 31 | Day |
Link to view the page
Value
https://center6.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000031616
